$TTRX
Turn Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$11.39
▼-5.87%-$0.710
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateTurn Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $13.80 at 09:31 AM on Sep 18, then ran to $16.45 +19% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is TTRX down today? It is at $11.39 (-5.87%), and our scanner flagged it 41 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TTRX spikes, and full due diligence on TTRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TTRX 41 times in the last 30 days. Create a free account to track $TTRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
TTRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on TTRX today, peaking at 2.2x its normal volume.
Likely catalyst6 GX-03 for AD Phase 2 Ongoing IL-31 IL-4 IL-36, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Burnam Bradley Evan Officer | Sold (automatic/other) | -600K 2.0% of company | sold 3.8% | 15.12M | n/a | May 28, 26 |
Burnam Bradley Evan Officer | Acquired (grant/award) | +600K 2.0% of company | added 4.0% | 15.72M | n/a | May 28, 26 |
Golden Arthur F Director | Acquired (grant/award) | +300K 1.0% of company | added 100% | 361K | n/a | Apr 2, 26 |
Burnam Bradley Evan Officer | Sold (automatic/other) | -300K 1.0% of company | sold 1.9% | 15.72M | n/a | Apr 2, 26 |
Dewhurst Martin William Director | Acquired (grant/award) | +22K 0.07% of company | n/a | 22K | n/a | Jan 7, 26 |
Chaudhary Zuraiz Officer | Bought (open market) | +3K | added 25% | 13K | $9K at $3.50 | Dec 12, 25 |
Golden Arthur F Director | Bought (open market) | +10K 0.03% of company | added 19% | 61K | $34K at $3.44 | Nov 24, 25 |
Chaudhary Zuraiz Officer | Bought (open market) | +1K | added 11% | 10K | $3K at $3.29 | Nov 21, 25 |
Golden Arthur F Director | Bought (open market) | +21K 0.07% of company | added 68% | 51K | $59K at $2.87 | Nov 21, 25 |
Chaudhary Zuraiz Officer | Bought (open market) | +1K | added 19% | 9K | $4K at $2.61 | Nov 20, 25 |
Chaudhary Zuraiz Officer | Bought (open market) | +3K | added 50% | 8K | $9K at $3.62 | Nov 17, 25 |
Golden Arthur F Director | Bought (open market) | +20K 0.07% of company | added 100% | 30K | $100K at $4.95 | Oct 23, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
TTRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on TTRX today, peaking at 2.2x its normal volume.
TTRX last traded at $11.39, down 5.87% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Turn Therapeutics Inc. Common Stock (TTRX) is next expected to report earnings on Thursday, November 12, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TTRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TTRX 41 times in the last 30 days.
TTRX (Turn Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $346M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TTRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TTRX discussion
Sign in to ask a question or join the discussion.